Active substance - Standardised immunocyanin
Indications - Relapse prevention of superficial carcinoma of the bladder [Tis, Ta–T1(G1–G3)] after transurethral resection. IMMUCOTHEL® constitutes only second line treatment in immunological treatment for relapse prevention.
-
Patients appreciate the well-tolerated alternative
- less distressing side effects
- effective alternative to BCG
- established treatment in several countries
- easy, no-cost disposal
IMMUCOTHEL® 1 mg dry substance with solvent Powder and solvent for solution for injection
IMMUCOTHEL® 10 mg dry substance with solvent Powder and solvent for solution for intravesical use